メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
新敗血症定義に準拠した敗血症総合検査システム構築と国内及び東南アジアへ運用展開
Kitajima, Isao
(PI)
役員
概要
フィンガープリント
研究成果
(10)
フィンガープリント
このプロジェクトで扱った研究トピックを検索します。これらのラベルは、プロジェクトの研究費/助成金に基づいて生成されます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Intrauterine Inflammation
93%
Cerebrospinal Fluid
93%
Temperature Mapping
77%
Mapping Method
77%
Klebsiella Pneumoniae (K. pneumoniae)
70%
Preterm Labor
65%
Melting Temperature
62%
Rapid Identification
62%
Streptococcus Pneumoniae
58%
Intact Membrane
56%
Microorganisms
56%
Retrospective Cohort Study
52%
S. Pneumoniae
48%
Pharmacokinetics
48%
Staphylococcus Aureus Bacteremia
46%
Sludge
46%
Blood Culture Collection
46%
Infectious Diseases Consultation
46%
Legionella
46%
Japanese Society
46%
Human Lymphocytes
46%
Methicillin-resistant Staphylococcus Aureus
46%
Slackia Exigua
46%
Hypervirulent Klebsiella Pneumoniae
46%
Infectious Diseases
46%
Mitochondrial Myopathy
46%
Clinical Microbiology
46%
Genome Sequencing
46%
S. Exigua
46%
Candida Species
46%
Amyotrophic Lateral Sclerosis
46%
Potential Biomarkers
46%
Antigen Test Kit
46%
Amniotic Fluid Sludge
46%
Bacteremia
46%
In Situ Hybridization
46%
Legionella Pneumonia
46%
Pyogenic Liver Abscess
46%
Nationwide Surveillance
46%
Candidemia
46%
17-hydroxyprogesterone (17-OHP)
46%
Urinary Antigen Test
46%
Adenosine Triphosphate
46%
Clinical Efficacy
46%
Blood Samples
46%
Bacterial Respiratory Pathogens
46%
Japanese Pediatric Patients
46%
Antibacterial Susceptibility
46%
Encephalopathy
46%
Linezolid
46%
Flow Cytometry Assay
46%
Lactic Acidosis
46%
Stroke-like Episode
46%
Chemotherapy
46%
Simple Renal Cyst
46%
Quenching Probe
37%
Japan
35%
Pathogenic Microorganisms
31%
BinaxNOW
31%
Amniotic Fluid
28%
Myopathy
28%
Whole Blood Sample
28%
Pediatric Patients
25%
Right-sided
24%
Patient Samples
24%
Accurate Identification
23%
Individual Cells
23%
Energy Transfer
23%
Antimicrobial Susceptibility
23%
In Situ PCR
23%
Inhibit Tumor
23%
Tumor Necrosis Factor-α
23%
Flow Cytometric
23%
Fluorescent Detector
23%
Nucleotide Sequence
23%
Legionella Pneumophila
23%
Tumor Necrosis Factor-α Converting Enzyme
23%
Fluorescent Indicator
23%
Human Serum
23%
Influenza
23%
Phosphorylation
23%
Gargle
23%
Concerted Reaction
23%
Sitafloxacin
23%
β-lactamase
23%
Lipopolysaccharide
23%
Haemophilus Influenzae
23%
THP-1 Cells
23%
Flow Cytometry
23%
Ampicillin Resistance
23%
Targeted Sequencing
23%
Resistant Strains
23%
Labelled Primers
23%
Nasopharyngeal Swab
23%
Tedizolid
23%
Thrombocytopenia
21%
Pleural Effusion
18%
Disease Activity
18%
Antimicrobial Stewardship
18%
Assay System
17%
Treatment Group
17%
Clinical Characteristics
15%
Abscess
15%
Intravenous Antibiotic Therapy
15%
Hypervirulent
15%
MagA
15%
Sequence Type 23
15%
Healthy children
15%
Serotype K1
15%
String Test
15%
Healthy Boys
15%
Hospital-acquired Bacteraemia
15%
Back Pain
15%
Clinical Variants
15%
RmpA
15%
Klebsiella Pneumoniae Liver Abscess
15%
Liver Abscess
15%
Abdominal Computed Tomography
15%
Peripheral Blood
15%
Serogroup
15%
Older Men
15%
High Fever
15%
Interleukin-8
15%
Newly Established
13%
Highly Sensitive
13%
Luciferase
13%
Idiopathic Normal Pressure Hydrocephalus (iNPH)
12%
Staphylococcus Aureus
11%
Penicillin
11%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Methicillin-resistant S. Aureus
11%
Respiratory Infection
11%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
11%
Clinical Specimens
11%
Streptococcus Pyogenes (S. pyogenes)
11%
Clinical Laboratory Standards Institute
11%
Extended-spectrum-lactamase
11%
Susceptibility Testing
11%
Metallo-β-lactamase
11%
Subgroup A
11%
Adult Patients
11%
Moraxella Catarrhalis
11%
Reference Laboratory
11%
Optimal Treatment
9%
Candida
9%
Life Expectancy
9%
Bacterial Infection
9%
High Mortality Rate
9%
Blood Fluid
9%
Chest X-ray
9%
White Blood Cell Count
9%
Thermostable DNA Polymerase
9%
Intra-amniotic Infection
9%
Occlusion
9%
Eukaryotes
9%
Quantitative PCR
9%
Japanese children
9%
Sequence Method
9%
Positive Rate
9%
Histologic Chorioamnionitis
9%
Blind Test
9%
Antifungal Stewardship
9%
Antifungal Therapy
9%
Blood Collection
9%
Rapid Methods
9%
Crude Mortality
9%
D-value
9%
Drainage Culture
9%
Rapid Diagnosis
9%
Invasive Pneumococcal Disease
9%
Antibiotic Administration
9%
Cost-based
9%
PCR Method
9%
Effective Antibiotics
9%
Renal Cyst
9%
Transvaginal Sonography
9%
Cerebral Vessels
9%
Lactate Level
9%
Fever
9%
Disease Monitoring
9%
Blood Culture
9%
Oxidative Phosphorylation (OXPHOS)
9%
Old Japanese
9%
Diagnostic Biomarker
9%
Transient Performance Improvement
9%
Four-year-olds
9%
Cerebrospinal Fluid Lactate
9%
Leptomeningeal
9%
Three-year-olds
9%
Cerebral Parenchyma
9%
Mitochondrial Encephalopathy
9%
Medical Costs
9%
Inferior Vena Cava
9%
16S rRNA Gene
9%
Stroke Mimics
9%
Pneumonitis
9%
Respiratory Conditions
9%
Novel Disease
9%
ATP Assay
9%
C-reactive Protein Level
9%
Medicine and Dentistry
Infection
100%
Pneumococcus
70%
Antiinfective Agent
66%
Klebsiella pneumoniae
58%
Premature Labor
58%
Bloodstream Infection
46%
Amnion Fluid
46%
Lymphocyte
46%
Chemotherapy
46%
Renal Cyst
46%
Pathogen
46%
Pyogenic Liver Abscess
46%
Penicillinase
46%
Flow Cytometry
46%
Urinary System
46%
Legionella
46%
In Situ Hybridization
31%
Ampicillin
23%
Sensitivity and Specificity
23%
Staphylococcus Aureus
23%
Antibiogram
23%
Haemophilus influenzae
23%
Reverse Transcription Polymerase Chain Reaction
23%
Nasopharyngeal Swab
23%
Pseudomonas aeruginosa
23%
Serotype
22%
Liver Abscess
18%
RNA 16S
15%
Nucleotide Sequence
15%
DNA Sequence
15%
Genomic DNA
15%
Energy Transfer
15%
Interleukin 8
15%
Pleura Effusion
13%
Streptococcus pyogenes
11%
Meticillin
11%
Penicillin Derivative
11%
Moraxella catarrhalis
11%
Nose Smear
11%
Reverse Transcription
11%
Influenza B
11%
Influenza Virus
11%
Influenza A
11%
Flu Like Syndrome
11%
Respiratory Tract Infection
11%
Comorbidity
9%
Antibiotic Therapy
9%
Backache
9%
Gemella morbillorum
9%
Retrospective Cohort Study
9%
Odontogenic Infection
9%
Community Acquired Infection
9%
Abdominal Abscess
9%
Hydroxyprogesterone
9%
Hydroxyprogesterone Caproate
9%
Computer Assisted Tomography
9%
Gene Sequence
9%
Pleural Empyema
9%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
9%
High Fever
9%
RNA Gene
9%
Abscess
9%
Diffuse Large B-Cell Lymphoma
9%
Cohort Effect
9%
Pus
6%
Pneumonia
6%
DNA 16S
6%
Pleuroperitoneal
6%
Inferior Vena Cava
6%
Catheter Infection
6%
Pneumococcal Infection
6%
Blood Culture
6%
Bacterial Infection
6%
Chest Radiograph
6%
C Reactive Protein
6%
Cell Count
6%
Health Care Cost
6%
Leukocyte
6%
Case Presentation
6%
Pregnancy
5%
Amnionitis
5%
DNA Polymerase
5%
Chorioamnionitis
5%
Vaginal Ultrasonography
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
93%
Biological Marker
55%
Infection
49%
Inflammation
49%
Pharmacokinetics
48%
MELAS Syndrome
46%
Microorganism
46%
Methicillin Resistant Staphylococcus Aureus Infection
46%
Candida
46%
Candidemia
46%
Cerebrovascular Accident
46%
Legionella
46%
Cohort Study
46%
Linezolid
46%
Amyotrophic Lateral Sclerosis
46%
Lactic Acidosis
46%
Brain Disease
35%
Myopathy
35%
Lipopolysaccharide
23%
Tumor Necrosis Factor
23%
High Performance Liquid Chromatography
23%
Disease Activity
23%
Premature Labor
23%
Tumor Necrosis Factor Alpha Converting Enzyme
23%
Sitafloxacin
23%
Tedizolid
23%
Thrombocytopenia
21%
Luciferase
15%
Normotensive Hydrocephalus
12%
DNA Polymerase
11%
Interleukin 8
11%
Disease
11%
Lactic Acid
11%
Chorioamnionitis
11%
Amnionitis
11%
Eukaryote
11%
Mitochondrial Encephalopathy
11%
Disease Severity
8%
Creatinine
8%
C Reactive Protein
8%
Cmin
8%
Mortality Rate
7%
Antifungal Agent
7%
Antifungal Therapy
7%
Life Expectancy
7%
Quinoline Derived Antiinfective Agent
5%
Sepsis
5%